Categories: Research

Update from the Dean – July 2018

Health at the molecular level: Decoding cellular signals, A trigger for tissue repair, Seeding tomorrow’s science. The future of custom care: Tracking cancer drug resistance, Treating malaria and tuberculosis, Quantitative Biosciences Institute’s culture of inclusivity, The genetics of asthma....

Drilling down to the details of opioid signaling

Despite using opioids for centuries for pain management, we still don’t have a complete understanding of how drugs like morphine and oxycodone actually work. And that’s a problem for patients, who must weather side effects that can range from nausea and constipation to cognitive impairment,...

It’s in the DNA: pharmacogenetics class

In BPS 115, (Genetics and Pharmacogenetics), first year PharmD students study themselves at a genetic level using pharmacogenetic testing, and volunteer to share their data with each other. Data is aggregated for selected drug metabolizing genes-of-interest.

Manglik named 2018 Pew Biomedical Scholar

Aashish Manglik, MD, PhD, the newest member of the faculty of the UCSF School of Pharmacy’s Department of Pharmaceutical Chemistry, was named a Pew Biomedical

Seiple named a 2018 Beckman Young Investigator

The Beckman Young Investigator award provides research support to the most promising young faculty members in the early stages of their academic careers in the chemical and life sciences.

Tumor analysis, prediction of transplant complications, and management of blood potassium levels take top honors at annual seminar

The Gary Rifkind Awards recognize and celebrate clinical pharmacy research.

Data for a difference

Low-cost drug treatments can cure TB and malaria. Why, then, do these diseases claim so many lives?

Research outlines challenges for adoption of new genetic tests

Every day, on average, ten new genetic tests become commercially available to help doctors and patients make more informed decisions about health care.

Pages